Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors

Neoplasia

Volumn 11, Issue 9, 2009, Pages 889-900

  Vishwanath, Karthik ^a   Yuan, Hong ^b   Barry, William T ^c   Dewhirst, Mark W ^c   Ramanujam, Nimmi ^a  

^a Duke University   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; HEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD OXYGEN TENSION; CANCER CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEOXYGENATION; DIFFUSE REFLECTANCE SPECTROSCOPY; EVALUATION; FEASIBILITY STUDY; FEMALE; FIBER OPTICS; GROWTH RATE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LIGHT ABSORPTION; LIGHT SCATTERING; MAXIMUM TOLERATED DOSE; MONTE CARLO METHOD; MOUSE; NONHUMAN; NUDE MOUSE; OPTIMAL DRUG DOSE; OXYGENATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID TUMOR; SPECTRAL SENSITIVITY; TISSUE NECROSIS; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; FEMALE; FIBER OPTIC TECHNOLOGY; HEMOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; LONGITUDINAL STUDIES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MONTE CARLO METHOD; OXYGEN; SPECTROPHOTOMETRY;

EID: 69249140209     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09580     Document Type: Article

References (43)

1. Herzig M and Christofori G (2002). Recent advances in cancer research: mouse models of tumorigenesis. Biochim Biophys Acta 1602, 97-113.
2. Degenhardt K and White E (2006). A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res 12, 5298-5304.
3. Cespedes MV, Casanova I, Parreno M, and Mangues R (2006). Mouse models in oncogenesis and cancer therapy. Clin Transl Oncol 8, 318-329.
4. Tozer GM, Prise VE, Wilson J, Cemazar M, Shan S, Dewhirst MW, Barber PR, Vojnovic B, and Chaplin DJ (2001). Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res 61, 6413-6422.
5. Young SL and Chaplin DJ (2004). Combretastatin A4 phosphate: background and current clinical status. Expert Opin Investig Drugs 13, 1171-1182.
6. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, et al. (2006). Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313, 1785-1787.
7. Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, Li CY, and Dewhirst MW (2005). Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8, 99-110.
8. Hockel M and Vaupel P (2001). Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93, 266-276.
9. Vaupel P and Harrison L (2004). Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9 (Suppl 5), 4-9.
10. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, et al. (2006). Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82, 699-757.
11. Seddon BM, Honess DJ, Vojnovic B, Tozer GM, and Workman P (2001). Measurement of tumor oxygenation: in vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumor. Radiat Res 155, 837-846.
12. Verheij M (2008). Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev 27, 471-480.
13. Inoue M, Takakuwa T, Minami M, Shiono H, Utsumi T, Kadota Y, Nasu T, Aozasa K, and Okumura M (2008). Clinicopathologic factors influencing postoperative prognosis in patients with small-sized adenocarcinoma of the lung. J Thorac Cardiovasc Surg 135, 830-836.
14. Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, et al. (2008). Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol 180, 1284-1289.
15. Ullrich E, Bonmort M, Mignot G, Kroemer G, and Zitvogel L (2008). Tumor stress, cell death and the ensuing immune response. Cell Death Differ 15, 21-28.
16. Torigian DA, Huang SS, Houseni M, and Alavi A (2007). Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin 57, 206-224.
17. Neves AA and Brindle KM (2006). Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 1766, 242-261.
18. Xu RX and Povoski SP (2007). Diffuse optical imaging and spectroscopy for cancer. Expert Rev Med Devices 4, 83-95.
19. Richards-Kortum R and Sevick-Muraca E (1996). Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 47, 555-606.
20. Bigio IJ and Bown SG (2004). Spectroscopic sensing of cancer and cancer therapy: current status of translational research. Cancer Biol Ther 3, 259-267.
21. Hielscher AH, Bluestone AY, Abdoulaev GS, Klose AD, Lasker J, Stewart M, Netz U, and Beuthan J (2002). Near-infrared diffuse optical tomography. Dis Markers 18, 313-337.
22. Palmer GM and Ramanujam N (2006). Monte Carlo-based inverse model for calculating tissue optical properties. Part I: Theory and validation on synthetic phantoms. Appl Opt 45, 1062-1071.
23. Tannock I (1982). Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation. Cancer Res 42, 4921-4926.
24. Arteel GE, Thurman RG, Yates JM, and Raleigh JA (1995). Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72, 889-895.
25. Prahl S (2001). Available at: http://omlc.ogi.edu/spectra/hemoglobin/ index.html.
26. van Gemert MJ, Jacques S, Sterenborg HJ, and Star W (1989). Skin optics. IEEE Trans Biomed Eng 36, 1146-1154.
27. Wang L, Jacques SL, and Zheng L (1995). MCML - Monte Carlo modeling of light transport in multi-layered tissues. Comput Methods Programs Biomed 47, 131-146.
28. Cheong W-F, Prahl S, and Welch S (1990). A review of the optical properties of biological tissues. IEEE J Quantum Electron 26, 2166-2185.
29. Diggle PJ (1988). An approach to the analysis of repeated measurements. Biometrics 44, 959-971.
30. Gart JJ, Krewski D, Lee PN, Tarone RE, and Wahrendorf J (1986). Statistical methods in cancer research. Volume III - The design and analysis of long-term animal experiments. IARC Sci Publ 79, 1-219.
31. Sorg BS, Moeller BJ, Donovan O, Cao Y, and Dewhirst MW (2005). Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt 10, 44004.
32. Teicher BA, Holden SA, Ara G, Dupuis NP, Liu F, Yuan J, Ikebe M, and Kakeji Y (1995). Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer 61, 732-737.
33. Tao K, Fang M, Alroy J, and Sahagian GG (2008). Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8, 228.
34. Toyota N, Strebel FR, Stephens LC, Matsuda H, Oshiro T, Jenkins GN, and Bull JM (1998). Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma. Int J Cancer 76, 499-505.
35. Shan S, Sorg B, and Dewhirst MW (2003). A novel rodent mammary window of orthotopic breast cancer for intravital microscopy. Microvasc Res 65, 109-117.
36. Albertsson P, Lennernas B, and Norrby K (2003). Chemotherapy and antiangiogenesis: drug-specific effects on microvessel sprouting. APMIS 111, 995-1003.
37. Albertsson P, Lennernas B, and Norrby K (2006). On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A. Acta Oncol 45, 144-155.
38. Durand RE and LePard NE (1994). Modulation of tumor hypoxia by conventional chemotherapeutic agents. Int J Radiat Oncol Biol Phys 29, 481-486.
39. Mourant JR, Freyer JP, Hielscher AH, Eick AA, Shen D, and Johnson TM (1998). Mechanisms of light scattering from biological cells relevant to noninvasive optical-tissue diagnostics. Appl Opt 37, 3586-3593.
40. Chang VT, Cartwright PS, Bean SM, Palmer GM, Bentley RC, and Ramanujam N (2009). Quantitative physiology of the precancerous cervix in vivo through optical spectroscopy. Neoplasia 11, 325-332.
41. Cerussi AE, Shah N, Hsiang D, Durkin A, Butler J, and Tromberg B (2006). In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 11, 044005.
42. Beauvoit B, Kitai T, and Chance B (1994). Contribution of the mitochondrial compartment to the optical properties of the rat liver: a theoretical and practical approach. Biophys J 67, 2501-2510.
43. Drezek R, Guillaud M, Collier T, Boiko I, Malpica A, Macaulay C, Follen M, and Richards-Kortum R (2003). Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt 8, 7-16.